-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
February 10, 2016 - tonsillitis has itself been defined as (1) five or more episodes of true tonsillitis a year … ;; (2) symptoms for
at least a year;; and (3) episodes that are disabling and prevent …
-Severity of throat infections
-Number of streptococcal
infections/year
Quality … Indications for tonsillectomy: a 10 year
retrospective review. …
Publication
year=1980-present
for all KQ
Publication year for KQ 3-
5=2000-present
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear-surveillance-140925.pdf
February 01, 2014 - cuff repair in small to
medium-sized tears: a randomized
controlled trial in 100 patients with 1-
year … Platelet rich plasma in arthroscopic
rotator cuff repair: a prospective RCT
study, 2-year follow-up … Appendix C: Evidence Table (Cycle 3/3rd Assessment)
Author Year … Author Year … Author year
Study name
(if applicable)
Study
design Subjects Treatment groups (n; dose) Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/dp5_summary.pdf
January 01, 2009 - Beneficiary Count Claim Count
No. of No. of
File Type Year Category
No. of
Categories Mean Minimum … 413,048 3,804
HH 2009 3-digit ICD-9 940 4,975 1 148 396,662 180 7,052 1 178 759,333 169
File Type Year … Inpatient 2009 5-digit ICD-9 8,518 1,592 1 28 473,184 3162 1,721 1 29 513,214 3,142
File Type Year … 1,333,457 1
SNF 2008 Chapter & HRR 5,523 454 1 159 58,963 779 1,019 1 369 71,831 557
File Type Year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
December 31, 2013 - These high-risk individuals have a 10-year
CHD risk greater than 20 percent, and their LDL-c target … Moderate-
risk patients are those with two or more risk factors and a 10-year CHD risk less than 20 … For moderate-risk
patients with a 10-year CHD risk of 10 to 20 percent, providers should consider drug … therapy
if the LDL-c is above 130 mg/dL; whereas for moderate-risk patients with a 10-year CHD risk … We
will also examine moderate-risk patients, that is, those with a 10-year risk of CHD of 10 to 20
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
June 13, 2013 - Smoking status
j. 10-year coronary heart disease (CHD) risk
k. History of CAD
3. … Smoking status
j. 10-year coronary heart disease (CHD) risk
k. … Short-term outcomes (all-cause mortality and MACE during the initial
hospitalization or within 1 year … Smoking status
j. 10-year CHD risk
k. History of CAD
4. … MACE
o Long-term outcomes
– All-cause mortality
– ≥1 year MACE rates
Type of
study
• We
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbi-protocol.pdf
August 09, 2021 - analyze
outcomes at the following intervals (comparative effectiveness and cosmesis outcomes: >=1 year … For KQ2b, single-arm studies with fewer than 50 patients
or fewer than 5-year followup will be excluded … Twenty-year follow-up of a randomized trial
comparing total mastectomy, lumpectomy, and lumpectomy plus … Effect of
radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast
cancer … Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast
irradiation using
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f-surv-rept-1-acute-pain.xlsx
May 29, 2025 - Risk of bias assessment for randomized controlled trials
Author, Year
(Full Citations Are Listed in
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
March 01, 2013 - Golimumab in psoriatic
arthritis: one-year clinical efficacy,
radiographic, and safety results from … Evidence Table
Author, Year Study Design Study name Drugs Year
conducted
N,
Population
F/U … Study Design Study name Drugs Year
conducted
N,
Population
F/U
Length
Efficacy / effectiveness … Author, Year Study Design Study name Drugs Year
conducted
N,
Population
F/U
Length
Efficacy … Adverse events were
generally mild to
moderate in severity
and intensity. 5% of
Author, Year
-
effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
September 01, 2020 - studies
of CLPC (stages T1–T3a) treatments ≥5 years duration for mortality and metastases, and ≥1 year
-
effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
October 01, 2007 - to what extent they
change rate ratio estimates and reduce bias in a study of statin
treatment and 1-year … identified all users of statins during the
study period and assessed the time until death within 1 year … how increasing restriction criteria affects
the strength of an association between statin use and 1-year … comparator drug use as determined from pharmacy claims
was carried forward until censoring after 1 year … Finally, we eliminated
subjects with evidence of dementia or cancer in the past year.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
August 23, 2010 - These two types of nonmelanomatous
(NMSC) lesions, responsible for more than 800,000 cases per year, … .4 One study found that “melanoma incidence
rates had doubled in all socioeconomic groups over a 10-year … period”.5 Another study found that
melanoma incidence rates have increased by 3% per year in white … From qualified studies, we will extract data on the citation (first
author name, journal and year of
-
effectivehealthcare.ahrq.gov/sites/default/files/cultural-competence_disposition-comments.pdf
January 01, 2020 - Disposition of Comments for CER 170 Cultural Competence Health Disparities
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Improving Cultural Competence To Reduce Health Disparities
Draft review available for public comment from June 22, 2015 to July 20, 2015.
Research Rev…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
September 13, 2024 - The following data will be abstracted
• Study identifier (author) and publication year
• Study design … ((((abstract:
(addiction)))))))) AND (((((title: (ADHD))))) OR ((((abstract:
(ADHD))))))))) AND ((Year … ("Polydrug
Abuse")))) OR (((title: (polysubstance)))) OR (((abstract:
(polysubstance)))))) AND ((Year … consequence)) OR (abstract: (consequences)) OR (abstract:
(sequala)) OR (abstract: (sequalae))))) AND ((Year
-
effectivehealthcare.ahrq.gov/sites/default/files/bar-cohen_-eccs2012.pdf
January 01, 2012 - Also determine the
time period of the risk (over the next year, 10 years, a lifetime). … Decision Making
(4 of 4)
“Women diagnosed with early stage breast cancer have a 98 percent 5-‐year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - engagement
• No outcome of interest
Timing Original studies published from 2019
onwards, the year … age who received at least 2
prescription claims for a high-risk medication during the measurement
year … Characteristics of included systematic reviews
Type of
review
Author,
Year
# Studies Types of … We limited the studies discussed in
Review question 5 to published works since 2019, the year of the … ROBINS-I risk of bias assessment for nonrandomized studies
Author,
year
Confounding Selection
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
May 01, 2012 - especially irritability and moodiness, can lead to discontinuation, and use for several
months to a year … in combination with
psychosocial
treatments
Outcomes for
children and
parents*
6
Months/1
Year … Duration of the study is modest,
but experience has demonstrated that often at least a year is needed … A 23-year comparison. J
Abnorm Child Psychol 2003 Feb;31(1):1-
11. PMID: 12597695.
8. … HSRProj—using the same search as before, and limiting Initial Year range 2008-2011
aggression OR “
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
February 01, 2014 - find
appropriate population-based estimates of GI bleeds in the U.S. population, we relied on the year … the more complex Gail/NCI approach to estimate the
number of prevented or excess events per person year … We used an information preserving
approach to present our results using the NNT and NNH person-year … The USPSTF proposed to use risk prediction equations
to estimate the absolute 10-year risks of MI. … Baseline risk
Indicator (Incidence Rate) Source (Year)
MI ARIC2 Community Surveillance Component (1987
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-protocol.pdf
April 01, 2014 - and the American Psychological Association’s (APA) PsychINFO from 2009 to present, based
on the year … Timing: We will include studies published in 2009 or later, based on the year that the PQMP
program … Year 2007 position statement: Principles and guidelines for early hearing detection and
intervention … of the listed outcomes
Timing • We will include studies published in 2009 or later, based on the year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ambulatory-safety_research-protocol.pdf
July 24, 2015 - for the Technical Brief
The Agency for Healthcare Research and Quality (AHRQ) is launching a multi-year … initiative in Fiscal Year 2015 to expand the scientific evidence, strategies, and tools that
are available … Searches will begin with
the year 2000.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
October 01, 2017 - Intermittent Inhalded Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma
Comparative Effectiveness Review
Number 194
Intermittent Inhaled Corticosteroids and Long-Acting
Muscarinic Antagonists for Asthma
Executive Summary
Objectives and Rationale for the
Review
This report summarizes a systemati…